Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-01-04 Sale | 2023-01-05 8:26 pm | G1 Therapeutics Inc. | GTHX | Moses Jennifer K. CFO | 2,368 | $5.5238 | $13,080 | 102,420 (Direct) | View |
| 2022-01-05 Sale | 2022-01-05 8:25 pm | G1 Therapeutics Inc. | GTHX | Moses Jennifer K. CFO | 1,445 | $10.61 | $15,334 | 88,555 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-26 Option Award | 2024-06-28 4:05 pm | N/A 2034-06-26 | Viridian Therapeutics Inc. | VRDN | Moses Jennifer K. Director | 21,000 | $0 | 21,000 (Direct) | View |
| 2023-06-14 Option Award | 2023-06-16 7:54 pm | N/A 2033-06-14 | Viridian Therapeutics Inc. | VRDN | Moses Jennifer K. Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-05 8:26 pm | N/A 2033-01-03 | G1 Therapeutics Inc. | GTHX | Moses Jennifer K. CFO | 66,900 | $0 | 102,420 (Direct) | View |
| 2022-06-08 Option Award | 2022-06-10 07:30 am | N/A 2032-06-08 | Viridian Therapeutics Inc. | VRDN | Moses Jennifer K. Director | 12,500 | $0 | 12,500 (Direct) | View |
| 2022-02-01 Exercise | 2022-02-02 5:20 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Moses Jennifer K. CFO | 2,000 | $4.17 | 95,888 (Direct) | View |
| 2022-02-01 Exercise | 2022-02-02 5:20 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Moses Jennifer K. CFO | 333 | $3.72 | 95,888 (Direct) | View |
| 2022-02-01 Exercise | 2022-02-02 5:20 pm | N/A 2026-05-10 | G1 Therapeutics Inc. | GTHX | Moses Jennifer K. CFO | 2,333 | $0 | 95,888 (Direct) | View |
| 2022-01-03 Option Award | 2022-01-05 8:25 pm | N/A 2032-01-03 | G1 Therapeutics Inc. | GTHX | Moses Jennifer K. CFO | 65,000 | $0 | 88,555 (Direct) | View |
| 2021-07-14 Option Award | 2021-07-15 4:24 pm | N/A 2031-07-14 | Viridian Therapeutics Inc. | VRDN | Moses Jennifer K. Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2021-03-03 Exercise | 2021-03-04 4:54 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Moses Jennifer K. CFO | 3,000 | $3.72 | 25,333 (Direct) | View |
| 2021-03-03 Exercise | 2021-03-04 4:54 pm | N/A 2025-12-21 | G1 Therapeutics Inc. | GTHX | Moses Jennifer K. CFO | 3,000 | $0 | 25,333 (Direct) | View |
| 2021-01-04 Option Award | 2021-01-05 6:25 pm | N/A 2031-01-04 | G1 Therapeutics Inc. | GTHX | Moses Jennifer K. CFO | 69,000 | $0 | 80,000 (Direct) | View |
| 2020-03-13 Exercise | 2020-03-16 07:00 am | N/A N/A | G1 Therapeutics Inc. | GTHX | Moses Jennifer K. CFO | 2,000 | $3.72 | 14,333 (Direct) | View |
| 2020-03-13 Exercise | 2020-03-16 07:00 am | N/A 2025-12-21 | G1 Therapeutics Inc. | GTHX | Moses Jennifer K. CFO | 2,000 | $0 | 14,333 (Direct) | View |
| 2020-02-06 Option Award | 2020-02-07 4:14 pm | N/A 2030-02-06 | G1 Therapeutics Inc. | GTHX | Moses Jennifer K. CFO | 80,000 | $0 | 80,000 (Direct) | View |
| 2020-01-23 Exercise | 2020-01-24 4:58 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Moses Jennifer K. CFO | 1,000 | $3.72 | 14,333 (Direct) | View |
| 2020-01-23 Exercise | 2020-01-24 4:58 pm | N/A 2025-12-21 | G1 Therapeutics Inc. | GTHX | Moses Jennifer K. CFO | 1,000 | $0 | 14,333 (Direct) | View |